- Country: Belarus
- Summary: 11/25 Drug Eculizumab
- BYT Ref No: 130330129
- Deadline: 03 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: BYN 43145438
- Notice Type: Tender
- Document Ref. No.: AU20251117355036
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- 11/25 Drug Eculizumab
- Documents:
Prilogenie___Spetzifikatziya_lyubaya_valyuta.xlsx
1_Dogovor_k_auktzionnym_dokumentam_2025_rezidenty_proizvoditeli.doc
2_Dogovor_k_auktzionnym_dokumentam_2025_rezidenty_posredniki.doc
3_Kontrakt_k_auktzionnym_dokumentam_2025_nerezidenty_strany_EAES.doc
5_Prilogenie_k_dogovoru_postavki_s_rezidentom.xls
6_Prilogenie_k_kontraktu_s_nerezidentom.xlsx
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN11/25 Drug Eculizumab - Belarus Tender
The MOGILEV RUE "PHARMACY", a Government sector organization in Belarus, has announced a new tender for 11/25 Drug Eculizumab. This tender is published on BelarusTenders under BYT Ref No: 130330129 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-03.
The estimated tender value is BYN 43145438, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
